Remepy
Signal active
Organization
Contact Information
Overview
Remepy is biotechnology research pioneering hybrid drugs. The company believes that in the future, software applications will become an integral part of treatments offered by Pharma companies in the form of Hybrid Drugs. These will include both a software component and a traditional drug component - influencing patients via Hybrid Mechanisms of Action™.
It was founded in 2022 and is located in Ramat Gan, Tel Aviv.
About
Industries
Biotechnology, Health Care, Health Diagnostics
Founded
2022
Employees
11-50
Headquarters locations
Asia
Social
N/A
Profile Resume
Remepy headquartered in Asia, operates in the Biotechnology, Health Care, Health Diagnostics sector. The company focuses on Biotechnology and has secured $360.0M in funding across 24 round(s). With a team of 11-50 employees, Remepy is actively contributing to advancements in Biotechnology. Their latest funding round, Seed Round - Remepy, raised $10.0M. Discover more about their projects, partnerships, and impact on our platform.
Employees
N/A
Funding Rounds
Funding rounds
2
Investors
10
Lead Investors
0
Total Funding Amount
$15.0M
Details
2
Remepy has raised a total of $15.0M in funding over 2 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2023 | Seed | 5.0M | ||
| 2024 | Seed | 10.0M |
Investors
Remepy is funded by 12 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| TechAviv | - | FUNDING ROUND - TechAviv | 10.0M |
| PsyMed Ventures | - | FUNDING ROUND - PsyMed Ventures | 10.0M |
| Remepy | - | FUNDING ROUND - Remepy | 10.0M |
| Stage Next Ventures | - | FUNDING ROUND - Stage Next Ventures | 10.0M |
Recent Activity
There is no recent news or activity for this profile.